No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Metastatic Castration Resistant Prostate Cancer (MCRPC)
Clinical trials for patients diagnosed with metastatic prostate cancer that no longer responds to androgen deprivation treatment. (Stage 4)
Find Your Trial
Low Risk
Intermediate Risk
High Risk
Cancer Recurrence
Non-Metastatic Castration Resistant
Metastatic Castration Sensitive
Metastatic Castration Resistant
Study of AMG 509 in Subjects with Metastatic Castration-Resistant Prostate Cancer
This clinical trial is for patients who have metastatic castration resistant prostate cancer (mCRPC) and failed to respond to abiraterone acetate or enzalutamide (but not both) and to taxane-based chemotherapy.
This information is for educational purposes only and not intended as medical advice.
Patients should consult their medical doctor for advice and recommendations about specific clinical trials.